RT @BartsECMC
@TumorBoardTues @tompowles1 @MPishvaian @JohnEbbenMDPhD 3/15 #TumorBoardTuesday #BladderCancer

❌PET scan prior to✂️
🩻PET lacks sensitivity in MIBC (70% in prior study n=43)
📚@adamkibel_uro https://pubmed.ncbi.nlm.nih.gov/19652070/
clinically negative CT + bone scan, PET/CT had SNS of 70% in MIBC
🧑🏻‍⚕️🤝👴🏽 #SharedDecision 4 cycles neoadju gem+cis

RT @BartsECMC
@TumorBoardTues @tompowles1 @MPishvaian @JohnEbbenMDPhD 3/15 #TumorBoardTuesday #BladderCancer

❌PET scan prior to✂️
🩻PET lacks sensitivity in MIBC (70% in prior study n=43)
📚@adamkibel_uro https://pubmed.ncbi.nlm.nih.gov/19652070/
clinically negative CT + bone scan, PET/CT had SNS of 70% in MIBC
🧑🏻‍⚕️🤝👴🏽 #SharedDecision 4 cycles neoadju gem+cis

RT @BartsECMC
@TumorBoardTues @tompowles1 @MPishvaian @JohnEbbenMDPhD 3/15 #TumorBoardTuesday #BladderCancer

❌PET scan prior to✂️
🩻PET lacks sensitivity in MIBC (70% in prior study n=43)
📚@adamkibel_uro https://pubmed.ncbi.nlm.nih.gov/19652070/
clinically negative CT + bone scan, PET/CT had SNS of 70% in MIBC
🧑🏻‍⚕️🤝👴🏽 #SharedDecision 4 cycles neoadju gem+cis

RT @BartsECMC
@TumorBoardTues @tompowles1 @MPishvaian @JohnEbbenMDPhD 3/15 #TumorBoardTuesday #BladderCancer

❌PET scan prior to✂️
🩻PET lacks sensitivity in MIBC (70% in prior study n=43)
📚@adamkibel_uro https://pubmed.ncbi.nlm.nih.gov/19652070/
clinically negative CT + bone scan, PET/CT had SNS of 70% in MIBC
🧑🏻‍⚕️🤝👴🏽 #SharedDecision 4 cycles neoadju gem+cis

RT @BartsECMC
@TumorBoardTues @tompowles1 @MPishvaian @JohnEbbenMDPhD 3/15 #TumorBoardTuesday #BladderCancer

❌PET scan prior to✂️
🩻PET lacks sensitivity in MIBC (70% in prior study n=43)
📚@adamkibel_uro https://pubmed.ncbi.nlm.nih.gov/19652070/
clinically negative CT + bone scan, PET/CT had SNS of 70% in MIBC
🧑🏻‍⚕️🤝👴🏽 #SharedDecision 4 cycles neoadju gem+cis

RT @BartsECMC
@TumorBoardTues @tompowles1 @MPishvaian @JohnEbbenMDPhD 3/15 #TumorBoardTuesday #BladderCancer

❌PET scan prior to✂️
🩻PET lacks sensitivity in MIBC (70% in prior study n=43)
📚@adamkibel_uro https://pubmed.ncbi.nlm.nih.gov/19652070/
clinically negative CT + bone scan, PET/CT had SNS of 70% in MIBC
🧑🏻‍⚕️🤝👴🏽 #SharedDecision 4 cycles neoadju gem+cis

RT @IBDHorizons
#IBDHorizons23

Male fertility — consensus from the panel is male #IBD patients don’t necessarily have to discontinue use of MTX. All are case by case and #SharedDecision.

#IBDHorizons23

Male fertility — consensus from the panel is male #IBD patients don’t necessarily have to discontinue use of MTX. All are case by case and #SharedDecision.

RT @KlempnerSam
@TumorBoardTues ✨Claudin18.2 (CLDN18.2)✨

🧑Patient: You’re doing all of these tests. What cancers express CLDN18.2?

🤝 #SharedDecision

🩺 clinician: Great question

1️⃣ Gastric/GEJ
2️⃣ Pancreatic
3️⃣ Biliary Tract, #NSCLC, Ovarian (less common)

RT @KlempnerSam
@TumorBoardTues ✨Claudin18.2 (CLDN18.2)✨

🧑Patient: You’re doing all of these tests. What cancers express CLDN18.2?

🤝 #SharedDecision

🩺 clinician: Great question

1️⃣ Gastric/GEJ
2️⃣ Pancreatic
3️⃣ Biliary Tract, #NSCLC, Ovarian (less common)

RT @KlempnerSam
@TumorBoardTues ✨Claudin18.2 (CLDN18.2)✨

🧑Patient: You’re doing all of these tests. What cancers express CLDN18.2?

🤝 #SharedDecision

🩺 clinician: Great question

1️⃣ Gastric/GEJ
2️⃣ Pancreatic
3️⃣ Biliary Tract, #NSCLC, Ovarian (less common)

RT @JonAnker1
@TumorBoardTues @MattGalsky @IntegrityCE @AstraZeneca @tarekmd91 @michelle_a_tran @kai_tsao @GeneticsRach @sonpavde @roula_almufti @JLVasquez82 @MichalisLiontos @alirezaghoreifi @montypal 👨‍🦱 Patient heard about immune therapies, asks how that compares to chemotherapy.

👨‍🦱🤝👨🏻‍⚕️Discussed starting treatment 💉 #SharedDecision

🤨 What would you offer this patient?

RT @JonAnker1
@TumorBoardTues @MattGalsky @IntegrityCE @AstraZeneca @tarekmd91 @michelle_a_tran @kai_tsao @GeneticsRach @sonpavde @roula_almufti @JLVasquez82 @MichalisLiontos @alirezaghoreifi @montypal 👨‍🦱 Patient heard about immune therapies, asks how that compares to chemotherapy.

👨‍🦱🤝👨🏻‍⚕️Discussed starting treatment 💉 #SharedDecision

🤨 What would you offer this patient?

RT @JonAnker1
@TumorBoardTues @MattGalsky @IntegrityCE @AstraZeneca @tarekmd91 @michelle_a_tran @kai_tsao @GeneticsRach @sonpavde @roula_almufti @JLVasquez82 @MichalisLiontos @alirezaghoreifi @montypal 👨‍🦱 Patient heard about immune therapies, asks how that compares to chemotherapy.

👨‍🦱🤝👨🏻‍⚕️Discussed starting treatment 💉 #SharedDecision

🤨 What would you offer this patient?